Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5584861 | Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) | 2017 | 7 Pages |
Abstract
Our results strongly suggest that plasma concentrations of EPA and DHA influence aspirin effects on lipid mediators of CVD event risk where their concentrations are most beneficial when moderate, not high or low. These effects on HDL-C cholesterol and apoA-I exchange are novel. Personalized dosing of DHA in those who take aspirin may be a beneficial option for patients with type 2 diabetes mellitus.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Robert C. Block, Ashley Holub, Amir Abdolahi, Xin M. Tu, Shaker A. Mousa, Michael N. Oda,